Towa Pharmaceutical Co., Ltd. (FRA:6QC)

Towa Pharmaceutical Revenue

Towa Pharmaceutical had revenue of 65.33B JPY in the quarter ending September 30, 2025, with 7.38% growth. This brings the company's revenue in the last twelve months to 266.67B, up 9.32% year-over-year. In the fiscal year ending March 31, 2025, Towa Pharmaceutical had annual revenue of 259.59B with 13.89% growth.

• Revenue (ttm): 266.67B JPY
• Revenue Growth: +9.32%
• P/S Ratio: 0.57
• Revenue / Employee: 55.69M JPY
• Employees: 4,788
• Market Cap: 879.50M EUR

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	259.59B	31.66B	13.89%
Mar 31, 2024	227.93B	19.08B	9.13%
Mar 31, 2023	208.86B	43.24B	26.11%
Mar 31, 2022	165.62B	10.72B	6.92%
Mar 31, 2021	154.90B	44.52B	40.33%